Forbes September 16, 2024
It’s easier to have a car or refrigerator shipped to your home these days than a prescription. To get even the most common prescription drug still requires a visit to the doctor, a trip to the pharmacy, and a convoluted series of negotiations between insurers, middlemen, and pharmaceutical companies.
Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely.
This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition to the pharmaceutical supply chain.
For too long, middlemen like pharmacy benefit managers have taken advantage of the complexity of the...
Today's Sponsors
Today's Sponsor